NNIT A/S: NNIT expands collaboration with PANDORA

Udgivet den 29-12-2016  |  kl. 09:00  |  

Press release 

NNIT expands collaboration with PANDORA

New contract adds MS Dynamics AX support to the services delivered by NNIT to the global jewellery company.
                                               
Copenhagen, December 29, 2016 - NNIT, a leading provider of IT services and consultancy, signs additional contract with PANDORA.

With the new contract, NNIT will be providing application support to one of Denmark's largest corporate MS Dynamics AX installations.

PANDORA designs, manufactures and markets hand-finished and contemporary jewellery made from high-quality materials at affordable prices. The jewellery is sold in more than 100 countries on six continents through approximately 9,000 points of sale, including more than 2,000 concept stores. Since May 2016, NNIT has run PANDORAs global IT operations, including the global IT platform for the ERP system Dynamics AX.

Besides a robust IT platform, NNIT delivers onsite support for stores and offices across the globe. With the additional contract, application support is added to the services delivered. The additional contract, which amounts in the high two-digit DKKm range, initially runs for 4.5 years.

With NNIT we have chosen a partner who supports our future growth through the delivery of high-quality IT services says Peter Cabello Holmberg, CIO at PANDORA.

The agreement with NNIT is part of PANDORA's efforts to build a scalable and robust platform to support one of the largest corporate ERP-installations in Denmark. Jacob Hahn Michelsen, Senior Vice President and Head of Sales in NNIT, says:

The contract with PANDORA marks NNIT's solid footprint in the Danish market for Dynamics AX-services. Our offshore setup is unique and enables us to provide 24/7 support for stable and secure ERP systems, which is essential to our global clients.

********
More information
Helga Heyn, NNIT Communications, +45 30 77 81 41, hhey@nnit.com

About Pandora
PANDORA designs, manufactures and markets hand-finished and contemporary jewelry made from high-quality materials at affordable prices. PANDORA jewelry is sold in more than 100 countries on six continents through approximately 9,000 points of sale, including more than 2,000 concept stores.

Founded in 1982 and headquartered in Copenhagen, Denmark, PANDORA employs more than 18,000 people worldwide of whom approximately 12,000 are located in Gemopolis, Thailand, where the company manufactures its jewelry. PANDORA is publicly listed on the NASDAQ Copenhagen stock exchange in Denmark. In 2015, PANDORA's total revenue was DKK 16.7 billion (approximately EUR 2.2 billion). For more information, please visit www.pandoragroup.com.

About NNIT
NNIT A/S is one of Denmark's leading IT service providers and consultancies. NNIT A/S offers a wide range of IT services and solutions to its customers, primarily in the life sciences sector in Denmark and internationally and to customers in the public, enterprise and finance sectors in Denmark. NNIT A/S has more than 2,600 employees. For more information please visit www.nnit.com

NNIT expands collaboration with PANDORA


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NNIT A/S via Globenewswire

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed